You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 7,411,050


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,411,050
Title:Monoclonal blocking antibody to human RANKL
Abstract: Disclosed herein are kits for detecting RANKL protein or nucleic acids, the kits comprising isolated human RANKL polypeptides, RANKL nucleic acids and/or antibodies specific for RANKL.
Inventor(s): Anderson; Dirk M. (Seattle, WA)
Assignee: Immunex Corporation (Thousand Oaks, CA)
Application Number:10/802,133
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 7,411,050

Introduction

United States Patent 7,411,050, titled "Nucleic Acid Encoding a Monoclonal Antibody," is a significant patent in the field of biotechnology, particularly in the development of monoclonal antibodies. This analysis will delve into the claims of the patent, the broader patent landscape, and the strategic insights that can be derived from this examination.

Understanding the Patent Claims

To begin with, it is crucial to understand the specific claims made in the patent. These claims define the scope of the invention and what is protected under the patent.

Independent Claims

Independent claims are the broadest claims in a patent and define the core invention. For US Patent 7,411,050, these claims typically involve the nucleic acid sequences encoding the monoclonal antibody, the antibody itself, and methods of using the antibody.

Dependent Claims

Dependent claims are narrower and build upon the independent claims. They often specify particular aspects of the invention, such as specific nucleic acid sequences, antibody fragments, or specific uses of the antibody.

Patent Landscape Analysis

A comprehensive patent landscape analysis is essential to understand the position of US Patent 7,411,050 within the broader intellectual property landscape.

Geographical Spread

Understanding the geographical spread of similar patents helps in identifying where the technology is most prevalent and where it might be beneficial to file additional patents. For biotechnology patents, key regions often include the United States, Europe, and Japan, due to the presence of major pharmaceutical and biotech companies[3].

Patent Saturation

Determining the saturation level of the patent space involving monoclonal antibodies is critical. A highly saturated space indicates intense competition and may suggest that entering this space could be challenging. However, it also highlights areas where innovation is actively pursued, and new entrants might find opportunities by exploring alternative technologies or niche areas[3].

Competitors and New Entrants

Identifying competitors and new entrants in the patent space is vital. This involves analyzing the patent portfolios of key players in the biotechnology sector and monitoring new patent filings to anticipate future trends and potential competitors.

Tools and Resources for Patent Search

Several tools and resources are available for conducting a thorough patent search and landscape analysis.

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape. It provides modern interfaces and enhanced access to prior art, making it easier to conduct comprehensive searches[1].

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a holistic view of the patent family and related data such as classification and citation data[1].

International Patent Databases

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is essential to ensure global coverage and identify potential prior art or competing patents[1].

Strategic Insights from Patent Landscape Analysis

Time-Slicing and Trend Analysis

Analyzing the patent landscape over time (time-slicing) helps in identifying trends and shifts in technology focus. This can reveal areas where companies are ceasing or increasing their patent activities, indicating potential opportunities or threats[3].

Niche Patent Areas

Identifying underappreciated niche patent areas can provide strategic advantages. For example, if a company is focusing a significant portion of its resources on a niche technology, it may indicate a high potential for innovation and market dominance in that area[3].

Case Study: Monoclonal Antibodies

Monoclonal antibodies, such as those described in US Patent 7,411,050, are a highly competitive area within biotechnology. Here are some key points from a patent landscape analysis in this field:

  • Geographical Spread: Major players in the monoclonal antibody space are often based in the United States, Europe, and Japan.
  • Patent Saturation: The space is highly saturated, with numerous patents filed by pharmaceutical and biotech companies. This saturation indicates a high level of competition but also highlights the importance and potential of this technology area.
  • Competitors and New Entrants: Companies like Roche, Johnson & Johnson, and Pfizer are significant players. New entrants might include smaller biotech firms or academic institutions.

Going Beyond Known Competitors

A thorough patent landscape analysis involves searching beyond direct competitors. This broader approach can uncover hidden gems or emerging trends that might not be immediately apparent from a narrow focus on known competitors[3].

Example: Patent Landscape Matrix

Using tools like AcclaimIP’s landscape matrices, one can visualize the patent portfolio of a company and its competitors. For instance, mapping abandoned technology patents against the remainder of the patent portfolio can reveal strategic shifts and areas of focus over time[3].

Key Takeaways

  • Comprehensive Search: Use a combination of USPTO tools, international databases, and specialized software for a thorough patent search.
  • Geographical and Saturation Analysis: Understand the geographical spread and saturation level of the patent space to make informed decisions.
  • Competitor Analysis: Identify key competitors and new entrants to anticipate market trends.
  • Time-Slicing: Analyze patent activities over time to identify shifts in technology focus.
  • Niche Areas: Look for underappreciated niche patent areas for strategic advantages.

FAQs

Q1: What is the purpose of a patent landscape analysis? A patent landscape analysis helps attorneys, portfolio managers, and other IP professionals provide strategic advice by analyzing the broader patent landscape, identifying trends, competitors, and potential opportunities or threats.

Q2: How can I determine the geographical spread of a technology patent area? The geographical spread can be determined by analyzing patent filings across different regions and countries, using resources like the USPTO Patent Public Search and international patent databases.

Q3: What does a highly saturated patent space indicate? A highly saturated patent space indicates intense competition and may suggest that entering this space could be challenging. However, it also highlights areas where innovation is actively pursued.

Q4: Why is it important to search beyond known competitors? Searching beyond known competitors can uncover hidden trends, emerging technologies, and new entrants that might not be immediately apparent from a narrow focus on known competitors.

Q5: What tools are available for conducting a patent landscape analysis? Tools include the USPTO's Patent Public Search, Global Dossier, international patent databases like EPO and WIPO, and specialized software like AcclaimIP’s landscape matrices.

Sources

  1. USPTO: Search for patents - USPTO
  2. OSTI.GOV: An Evaluation of the Patent Portfolio Funded by the U.S. Department of Energy's Critical Materials Innovation Hub
  3. AcclaimIP: Patent Landscape Analysis - Uncovering Strategic Insights Patent ...

More… ↓

⤷  Subscribe

Details for Patent 7,411,050

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen Inc. PROLIA denosumab Injection 125320 June 01, 2010 ⤷  Subscribe 2016-12-23
Amgen Inc. XGEVA denosumab Injection 125320 November 18, 2010 ⤷  Subscribe 2016-12-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.